Fuchs' Endothelial Corneal Dystrophy and Cardiometabolic Comorbidities

Andrew Mihalache1, Ryan S Huang1, Marko M Popovic2

  • 1Temerty Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.

Ophthalmology
|March 6, 2026
PubMed

Insights

Individuals with Fuchs' endothelial corneal dystrophy showed a greater prevalence of cardiometabolic diseases compared to control groups. This finding highlights a potential link between corneal health and systemic metabolic conditions.

Area of Science:

  • Ophthalmology
  • Cardiology
  • Endocrinology

Background:

  • Fuchs' endothelial corneal dystrophy is a progressive eye condition affecting the cornea.
  • Cardiometabolic diseases encompass conditions like diabetes, obesity, and heart disease.
  • The relationship between ocular surface diseases and systemic health is an area of growing research interest.

Purpose of the Study:

  • To investigate the association between Fuchs' endothelial corneal dystrophy and cardiometabolic disease burden.
  • To compare cardiometabolic disease prevalence in patients with Fuchs' dystrophy versus a matched control cohort.

Main Methods:

  • Retrospective cohort study design.
  • Utilized data from the National Institutes of Health All of Us Research Program.
  • Included 548 individuals diagnosed with Fuchs' endothelial corneal dystrophy and 5,480 matched controls.

Main Results:

  • Patients with Fuchs' endothelial corneal dystrophy presented with a significantly higher burden of cardiometabolic disease.
  • The study identified a notable disparity in cardiometabolic risk factors between the case and control groups.

Conclusions:

  • Fuchs' endothelial corneal dystrophy may be associated with an increased prevalence of cardiometabolic diseases.
  • Further research is warranted to explore the underlying mechanisms and clinical implications of this association.
Abstract

No abstract available in PubMed .

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
593
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
689
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
851
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
694
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
722